Innovation Park Central Switzerland inaugurates new buildings
Rotkreuz ZG – After two years of temporary measures, Innovation Park Central Switzerland is moving into its new buildings in the Suurstoffi area of Rotkreuz. Three years after its founding, the Innovation Park has already amassed a total of 66 members.
Daniela Marino named Entrepreneur of the Year
Zurich/Schlieren ZH - Daniela Marino has been named Swiss Entrepreneur of the Year. The CEO of Cutiss was honored at the Female Innovation Forum. Bettina Hirsig of Powercoders received the recognition prize.
Alethena digitizes quitt.ch shares
Zug/Zurich – Domestic services provider quitt.ch has digitized its shares and made them freely tradable, without listing them on a stock exchange. This was made possible by a technology developed by Zug-based fintech Alethena.
Artificial intelligence explores the universe
Zurich – Researchers at the Federal Institute of Technology in Zurich have used artificial intelligence to learn more about dark matter and dark energy in the universe. This new approach will help them analyze data more precisely.
ETH produces successful employable graduates
Zurich – The Federal Institute of Technology in Zurich (ETH) is one of the best universities for career-driven students. It scooped 15th place in the QS Graduate Employability Ranking.
Greater Zurich Area has a new unicorn
Schaffhausen – The Schaffhausen software company Acronis has raised 147 million dollars in funding. This brings the company to unicorn status, with a value of more than one billion dollars.
Mikron machine wins award
Agno TI – Mikron has received this year’s MM Award for its rotary transfer machine Mikron MultiX. The award was presented at the EMO Hannover 2019 trade fair for the metalworking industry.
HSLU opens Zug-Rotkreuz campus
Rotkreuz ZG – The Zug-Rotkreuz campus of the Lucerne University of Applied Sciences and Arts has been officially opened. Around 1,350 finance and ICT students will be studying on this campus as of this autumn semester.
Researchers identify Achilles’ heel of multiple sclerosis therapy
Bellinzona – A research team led by Ticino scientists has discovered why the multiple sclerosis drug natalizumab is less effective in some patients. Based on this information, an alternative version has now been engineered.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space